Your browser doesn't support javascript.
loading
Metabolomics analysis reveals cytotoxic effects of ouabain towards psoriatic keratinocytes via impairment of glutathione metabolism.
Zhou, Xuan; Fei, Fei; Song, Wei; Ma, Hehua; Xu, Zhenzhen; Yue, Jing; Cao, Bei; Sun, Runbin; Zhao, Yu; Yang, Yuanxun; Jiang, Junyi; Geng, Yan; Weng, Zuyi; Li, Juan.
Afiliação
  • Zhou X; Phase I Clinical Trials Unit, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 359 Pu Zhu Middle Road, Nanjing, 210031, China.
  • Fei F; Phase I Clinical Trials Unit, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 359 Pu Zhu Middle Road, Nanjing, 210031, China.
  • Song W; Phase I Clinical Trials Unit, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 359 Pu Zhu Middle Road, Nanjing, 210031, China.
  • Ma H; Phase I Clinical Trials Unit, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 359 Pu Zhu Middle Road, Nanjing, 210031, China.
  • Xu Z; Phase I Clinical Trials Unit, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 359 Pu Zhu Middle Road, Nanjing, 210031, China.
  • Yue J; Phase I Clinical Trials Unit, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 359 Pu Zhu Middle Road, Nanjing, 210031, China.
  • Cao B; Phase I Clinical Trials Unit, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 359 Pu Zhu Middle Road, Nanjing, 210031, China.
  • Sun R; Phase I Clinical Trials Unit, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 359 Pu Zhu Middle Road, Nanjing, 210031, China.
  • Zhao Y; Phase I Clinical Trials Unit, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 359 Pu Zhu Middle Road, Nanjing, 210031, China.
  • Yang Y; Phase I Clinical Trials Unit, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 359 Pu Zhu Middle Road, Nanjing, 210031, China.
  • Jiang J; Phase I Clinical Trials Unit, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 359 Pu Zhu Middle Road, Nanjing, 210031, China.
  • Geng Y; Phase I Clinical Trials Unit, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 359 Pu Zhu Middle Road, Nanjing, 210031, China.
  • Weng Z; Phase I Clinical Trials Unit, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 359 Pu Zhu Middle Road, Nanjing, 210031, China. zuyiweng@163.com.
  • Li J; Phase I Clinical Trials Unit, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 359 Pu Zhu Middle Road, Nanjing, 210031, China. juanli2003@163.com.
Mol Genet Genomics ; 298(3): 567-577, 2023 May.
Article em En | MEDLINE | ID: mdl-36856826
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article